In 2015 the first ESMO Asia Congress welcomed nearly 3,000 medical and healthcare professionals from 75 countries with all participants benefitting from the expertise of the prestigious congress faculty and important clinical perspectives from regional and national oncology societies.
ESMO Asia 2016 will comprise both scientific and educational tracks prepared by an international scientific committee, all experts in their respective fields. The programme will have a strong emphasis on state of the art science, including a call for abstracts, and cover the current standard of care across all major tumour types. Interactive sessions will be dedicated to the latest ESMO Clinical Practice Guidelines and there will be opportunities for delegates to interact both with local experts and key opinion leaders from the international oncology community.
Consolidating activities in Asia underlines the importance ESMO places on collaboration with partners in this region. This second congress in Asia will again take place in Singapore, which has proven to have excellent meeting facilities and is a convenient travel hub for delegates from most countries.
ESMO Asia facilitates information exchange between Asian and European oncology professionals and offers a global benefit—the exchange of expertise across continents. On behalf of ESMO and the entire ESMO Asia 2016 Scientific Committee, we invite you to mark your calendars for ESMO Asia 2016, which aims to cover the latest findings, offer discussions on tangible patient outcomes and provide inspiration for what’s next in medical oncology.